Publication date: Jul 15, 2025
Although Seasonal Influenza Vaccination (SIV) is a crucial preventive measure, achieving sufficient coverage to completely control influenza epidemics poses a significant challenge. This study aims to evaluate optimal strategies for SIV to prevent high-intensity level of influenza epidemics in Zhejiang Province, China. High-intensity outbreaks were defined as weekly incidence rates above 72. 2 per 100,000. This study estimated the incidence of influenza from 2018 to 2023 in Zhejiang Province, China, using influenza weekly surveillance data. We developed a Susceptible-Vaccinated-Infectious-Recovered-Susceptible (SVIRS) model to simulate influenza transmission and used a decision tree to assess seven vaccination strategies aimed at preventing high-intensity influenza outbreaks. These strategies differed in vaccine coverage across the three age groups: 0-14 years, 15-59 years, and 60 + years, despite having the same overall vaccination coverage. Between 2018 and 2020, influenza incidence in Zhejiang Province followed typical seasonal patterns. However, during the COVID-19 pandemic, these patterns became irregular, culminating in a high-intensity influenza season in 2022-2023. Model simulations indicated that increasing population-wide vaccination coverage to 36. 17% could effectively prevent outbreaks from escalating to high-intensity levels. Among various allocation strategies for additional vaccines, targeting individuals aged 0-14 years and those aged 60 years and older was found to be the most effective. This approach reduced the peak weekly incidence rate from the observed 182. 83 to a predicted 42. 28 per 100,000, saved 23. 45 CNY per capita, and yielded a health gain of 0. 0102 quality-adjusted life days (QALDs) per person. Achieving a population-wide vaccination coverage beyond 36. 17% is projected to prevent high-intensity level of influenza epidemics. Targeting the 0-14 years and 60 + years age groups proves to be the most cost-effective strategy under constrained coverage conditions. These findings highlight the importance of age-prioritized vaccination policies to optimize resource allocation and mitigate the impact of influenza outbreaks, particularly in regions with limited healthcare capacity.
Open Access PDF
| Concepts | Keywords |
|---|---|
| China | Decision tree |
| Economic | Optimal vaccination strategy |
| Healthcare | Seasonal influenza vaccination |
| Influenza | Susceptible-vaccinated-infectious-recovered-susceptible model |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | influenza |
| disease | MESH | COVID-19 pandemic |
| disease | IDO | quality |
| pathway | REACTOME | Reproduction |
| drug | DRUGBANK | Stavudine |
| disease | MESH | infections |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | infectious diseases |
| disease | IDO | infection |
| drug | DRUGBANK | Aspartame |
| drug | DRUGBANK | Ilex paraguariensis leaf |
| drug | DRUGBANK | Methylergometrine |
| drug | DRUGBANK | L-Tyrosine |
| disease | MESH | death |
| disease | MESH | uncertainty |
| disease | MESH | privacy |
| disease | MESH | Emergency |
| disease | IDO | susceptibility |
| pathway | KEGG | Influenza A |
| drug | DRUGBANK | Tretamine |
| drug | DRUGBANK | Guanosine |
| disease | IDO | intervention |
| disease | MESH | parainfluenza |